Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia. These meetings allowed industry executives to meet and explore business opportunities with China’s emerging biotech sector. One company in particular, SciClone Pharmaceuticals, invited BioWorld to tag along for the day and get an insider’s look at what a full day of partnering entails. To better understand the full scope of participating in these partnering meetings, read the article here.
While 700 partnering meetings is impressive, this coming February’s BIO CEO & Investor Conference in New York City expects nearly double that amount. To learn more about the largest investor conference focused on established and emerging publicly traded and select private biotech companies and the BIO One-on-One PartneringTM System, visit here.